Quintiles Library

Precision Enrollment
Featured Video
Show Filters
Article
Healthcare systems and a variety of stakeholders are demanding convincing value data to show improved outcomes before approving new drugs. Quintiles' experts share their insight into combining strategic thinking with the ability to capture and analyze complex clinical data to effectively demonstrate real-world outcomes.  Learn why a clear understanding of stakeholder...
Explore More
Fact Sheet
Achieve better patient outcomes with fit-for-purpose study design and execution to meet the needs of regulators, payers, providers and patients. Quintiles’ dedicated real-world evidence team combines integrated partner services and operational expertise with innovative technology to guide you through the unique challenges of real-world evidence studies. Click on the...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. – July 13, 2016 – Quintiles Transnational Holdings Inc. (NYSE: Q) will release its second quarter 2016 financial results Wednesday, July 27, 2016 prior to its quarterly earnings call at 8:00 a.m. EDT. The conference call will be accessible, live via webcast, on the Investor Relations section of the Quintiles website at...
Read More
Presentation
Saumya Nayak, Manager, Patient and Site Services at Quintiles, shares insights into how China, the third largest pharmaceutical market, is following the US and Europe and shifting from product-centricity towards patient-centricity when conducting clinical trials. Topics discussed in this presentation are: Adopting a patient-centric clinical trial model The...
Explore More
White Paper
Quintiles’ HTA Watch is a web-based service offering instant access to a global repository of published HTA reports from nearly 100 agencies in 32 countries, providing regularly updated assessments to help inform life sciences and healthcare companies’ strategic decision-making*. In this edition of our HTA uncovered series, we will look specifically at the market access...
Explore More
White Paper
Our view on the future of biopharmaceutical research and development
Explore More
Fact Sheet
While rare diseases individually affect very few patients, the collective impact is staggering. Globally, the list of rare diseases has grown to approximately 7,000, and 350 million people are living with a rare disease. These diseases are serious, often life-threatening, and approximately half of those affected are children. The lack of available treatments leave...
Read More
Video
Dr. John Doyle & Jeanne Hecht discuss Evidence Optimization from DIA 2016. This presentation highlights innovative approaches to integrating evidence alongside scientific expertise, technology and global delivery.  
Video
Quintiles works with government officials, patient advocacy groups, physicians, and patents to accelerate knowledge sharing and decision making that benefits patients.  From promoting proactive clinical trial legislation to promoting patient engagement, we engage many persons to improve the probability of success for sponsors and investigators.  
Video
Jeanne Hecht discusses Transforming Patient Recruitment through Site & Patient Engagement at DIA 2016. Learn how we’re using innovative solutions and partnerships to transform the way patients impact study success.
Article
Patient registries have become a vital tool for clinical trials, giving researchers access to patient communities, advocates and real-world data to inform their protocols and improve their recruiting efforts. The impact of patient registries has been particularly beneficial for rare disease trials.
Explore More
Press Release
RESEARCH TRIANGLE PARK, N.C. – June 24, 2016 – Quintiles today announced the launch of its new Continuous Glucose Monitoring (CGM) service offering. This new solution combines innovative, wearable technology with Quintiles’ deep therapeutic and analytical expertise to help enhance the efficiency and quality of diabetes-focused clinical trials.  When used in clinical...
Read More
Infographic
Quintiles helps anticipate and address the complex challenges of rare disease studies by bringing together a specialized team with rare disease experience and therapeutic expertise, along with tailored patient-centric approaches to global study planning and execution in order to speed treatments to market to transform the lives of patients and their families.
Read More
Press Release
MORRISVILLE, N.C. – June 23, 2016 – Q2 Solutions, a global clinical trials laboratory services organization, today announced that the company has received the 2016 Lilly Global Supplier Award. Q2 Solutions was one of 12 companies to receive the award this year, recognizing the company’s ongoing contributions to Lilly’s drug development efforts.  Each year, the Lilly...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C. –  June 21, 2016 – Quintiles, the world’s largest provider of product development and integrated healthcare services, opened its global Solution Design Studio where expert teams will collaborate to create technology solutions that tackle some of healthcare’s biggest challenges.  The Studio is a highly interactive technology-driven environment...
Read More
Video
Quintiles has the tremendous opportunity to conquer disease and speed medicines to patients who need them most. Learn how our team of experts transform your clinical development by helping you create better, smarter, faster trials from planning and design to post-market approval.
Press Release
RESEARCH TRIANGLE PARK, NC – June 16, 2016 – Quintiles has been named the industry leader in Phase I, Phase II/III and Phase IV services, according to the Industry Standard Research’s (ISR) 2016 CRO Quality Benchmarking — Phases I, II/III and IV reports. Quintiles also was named the best service provider across all phases of clinical development for differentiation based...
Read More
Video
The field of cancer immunotherapy is developing quickly. Accordingly, there is a need for novel imaging modalities. Hear from Jeff Hodge, VP, Development Solutions, Oncology Center of Excellence, Quintiles, about immuno-PET technology and the importance of following changes in a patient’s immune system without having to take a biopsy or blood sample.
Fact Sheet
Comprehensive Insights Lead to Faster Critical Decisions Whether you’re a small biotechnology firm or a large pharmaceutical company – and regardless of the size or complexity of your study – Quintiles offers the right strategic and operational approach to meet your goals.
Read More
Video
Whether you need support with medical writing, developing a robust evidence generation strategy, or scaling your pivotal Phase III trial, Quintiles' solutions are tailored to meeting the needs of our emerging biopharma customers. This video takes you through the journey from early clinical to commercialization. Find out how you can benefit from personalized attention,...